|
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Arthritis Drugs Advisory Committee
April 12, 2007
Robert Levine, M.D.
• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]
Kenneth Saag, M.D.
• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]
Dennis Turk, Ph.D.
• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]
Page updated:
March 28, 2007
|
|